We are live on ! Find out more
RDUS

Radius Health, Inc.

Delisted

RDUS was delisted on the 12th of August, 2022.

127 hedge funds and large institutions have $960M invested in Radius Health, Inc. in 2019 Q1 according to their latest regulatory filings, with 24 funds opening new positions, 42 increasing their positions, 32 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

45% more call options, than puts

Call options by funds: $15.9M | Put options by funds: $11M

31% more repeat investments, than reductions

Existing positions increased: 42 | Existing positions reduced: 32

26% more first-time investments, than exits

New positions opened: 24 | Existing positions closed: 19

21% more capital invested

Capital invested by funds: $796M → $960M (+$164M)

3% more funds holding

Funds holding: 123127 (+4)

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

Holders
127
Holders Change
+4
Holders Change %
+3.25%
% of All Funds
2.75%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.04%
New
24
Increased
42
Reduced
32
Closed
19
Calls
$15.9M
Puts
$11M
Net Calls
+$4.89M
Net Calls Change
-$1.25M
Name Holding Trade Value Shares
Change
Change in
Stake
BB
1
BB Biotech
Switzerland
$135M +$1.3M +71,409 +1%
Vanguard Group
2
Vanguard Group
Pennsylvania
$81.9M +$1.08M +59,386 +1%
Wellington Management Group
3
Wellington Management Group
Massachusetts
$77M +$4.94M +270,676 +8%
HM
4
HealthCor Management
New York
$73.4M -$784K -43,000 -1%
BlackRock
5
BlackRock
New York
$66.6M +$525K +28,796 +0.9%
T. Rowe Price Associates
6
T. Rowe Price Associates
Maryland
$51.1M +$406K +22,283 +0.9%
State Street
7
State Street
Massachusetts
$42.2M -$2.69M -147,479 -7%
FCM
8
Farallon Capital Management
California
$40.7M
RCMNY
9
Rubric Capital Management (New York)
New York
$39.7M -$1.97M -107,922 -5%
Citadel Advisors
10
Citadel Advisors
Florida
$31.9M -$1.87M -102,350 -6%
Millennium Management
11
Millennium Management
New York
$28.4M -$7.24M -396,709 -22%
RSCM
12
Rock Springs Capital Management
Maryland
$23.4M +$1.37M +75,000 +7%
D.E. Shaw & Co
13
D.E. Shaw & Co
New York
$18.8M +$5.22M +286,310 +44%
Fidelity Investments
14
Fidelity Investments
Massachusetts
$18M -$1.62M -88,946 -9%
Morgan Stanley
15
Morgan Stanley
New York
$17.4M -$3.13M -171,617 -16%
Hudson Bay Capital Management
16
Hudson Bay Capital Management
Connecticut
$14.8M -$2.19M -120,000 -14%
Artisan Partners
17
Artisan Partners
Wisconsin
$14.1M +$144K +7,872 +1%
SIM
18
Spark Investment Management
New York
$13.5M +$1.66M +91,200 +16%
EP
19
Eversept Partners
New York
$12.9M +$1.7M +93,364 +17%
Deutsche Bank
20
Deutsche Bank
Germany
$11.6M -$67.9K -3,722 -0.6%
TA
21
Teachers Advisors
New York
$10.5M +$708K +38,788 +8%
Geode Capital Management
22
Geode Capital Management
Massachusetts
$10.1M +$911K +49,966 +11%
Northern Trust
23
Northern Trust
Illinois
$9.9M +$114K +6,236 +1%
Man Group
24
Man Group
United Kingdom
$8.99M +$898K +49,250 +12%
Goldman Sachs
25
Goldman Sachs
New York
$7.43M -$2.51M -137,687 -27%

RDUS Hedge Fund Activity: Q1 2019 in Review

127 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in Radius Health, Inc. (RDUS) for Q1 2019, worth a combined $960M — up 21% from $796M a quarter earlier.

Buyers outnumbered sellers: 24 funds opened new RDUS positions and 19 closed out — a net gain of 5 holders — while 42 added to existing stakes and 32 trimmed.

The largest buyer was D.E. Shaw & Co, adding an estimated $5.22M. The largest seller was Citigroup, cutting an estimated $8.87M.

  • 127 institutional investors held Radius Health, Inc. (RDUS) as of Q1 2019, up from 123 in Q4 2018.
  • Funds reported $960M of Radius Health, Inc. stock for Q1 2019, up 21% quarter-over-quarter.
  • 24 funds opened new Radius Health, Inc. positions in Q1 2019 and 19 closed out, a net change of +5 holders.
  • The largest Radius Health, Inc. buyer in Q1 2019 was D.E. Shaw & Co, an estimated $5.22M added.
  • The largest Radius Health, Inc. seller in Q1 2019 was Citigroup, an estimated $8.87M sold.

Based on aggregated 13F filings for Q1 2019.